SEP 16, 2026 · JOURNAL ARTICLE
A hemoglobin >120g/L trends toward improved survival without increasing vascular events in ESA-treated MDS patients
Blood Advances
Erythropoiesis stimulating agents (ESAs) are recommended for treating anemia in lower-risk patients with MDS. Hemoglobin (Hb) levels <120g/L are mandated based on thrombosis-risk e